Varda
Spacecraft that make drug crystals in orbit and fly them home
FOUNDED
2021
FOUNDERS
Will Bruey and Delian Asparouhov
HEADQUARTERS
El Segundo, California
STATUS
Private
WEBSITE
Visit website
Some drug molecules crystallize differently without gravity. On Earth, sedimentation and convection disturb a growing crystal. In orbit those forces mostly fall away, which can yield more uniform crystals and forms that are hard to make on the ground. Varda’s first capsule, W-1, did this with the HIV drug ritonavir between 2023 and 2024.
The hard part is the trip home. Varda builds the whole vehicle in El Segundo. A satellite bus runs the experiment. Then a capsule separates and hits the atmosphere at about Mach 25, protected by a C‑PICA carbon ablator that NASA developed and Varda now makes in house. A parachute sets it down in South Australia.
On November 5, 2026, W-8 landed after 35 days in orbit. It was Varda’s seventh reentry since 2024. Five weeks earlier, Varda raised $251 million at a $1.6 billion valuation.
Company facts from public sources, November 2026
